1.Amer, MH, Al-Sarraf, M, Baker, HL. Malignant melanoma and central nervous system metastases: Incidence, diagnosis, treatment and survival. Cancer 1978; 42: 660–668.
2.Beresford, HR. Melanoma of the CNS treatment with corticoste-roids and radiation. Neurology (NY) 1969; 19: 59–65.
3.Bullard, DE, Cox, EB, Seigler, HF. Central nervous system metastases in malignant melanoma. Neurosurgery 1981; 8: 26–30.
4.Budman, DR, Camacho, E, Wittes, RE. The current causes of death in patients with malignant melanoma. Eur J Cancer 1978a; 14: 327–330.
5.Leigh, A. Melanoma of the central nervous system. Aust. NZ J Surg 1978; 48: 14–16.
6.Stehlin, JS Jr, Hills, WJ, Rufino, C. Disseminated melanoma biologic behaviour and treatment. Arch Surg 1967; 94: 495–501.
7.Byrne, TN, Cascino, TL, Posner, JB. Brain metastasis from melanoma. J Neuro-Oncology 1983; 1: 313:317.
8.Bauman, ML, Thomas, PR.Intracranial metastatic malignant melanoma; long term survival following subtotal resection. Southern Med J 1972; 65: 344ߝ346.
9.McCann, WP, Weir, BKA. Long term survival after removal of metastatic malignant melanoma of the brain. J Neurosurg 1968; 29: 483–487.
10.Cairncross, SG, Kim, JH, Posner, BJ. Radiation therapy for brain metastases. Ann Neur 1980; 7: 529–541.
11.McBride, CM. Diagnosis and management of malignant melanoma: some current approaches and controversies. In Seventh National Conference Proceedings pp 581-585 Philadelphia, J.B. Lippincott Co., 1973.
12.Fell, DA, Leavens, ME, McBride, CM. Surgical versus nonsurgical management of metastatic melanoma of the brain. Neurosurgery 1980; 7: 238–242.
13.Hilaries, BS, Raben, M, Calabrese, AS, et al. Value of radiation therapy for distant metastases from malignant melanoma. Cancer 1963; 18: 765–773.
14.Moon, JH. Combination chemotherapy of malignant melanoma. Cancer 1970; 25: 468–473.
15.Hafstrom, L, Jonsson, PE, Stromblad, LG. Intracranial metastasis of malignant melanoma treated by surgery. Cancer 1980; 46: 2088–2090.
16.Vieth, RG, Odom, GL. Intracranial metastases and their surgical treatment. J Neurosurg 1975; 23: 375–438.
17.McNeil, DP, Leavens, ME. Long term survival with recurrent metastatic intracranial melanoma. J. Neurosurg 1968; 29: 91–93.
18.Carella, RJ, Gelber, R, Hendrickson, F, et al. Value of radiation therapy in the management of patients with cerebral metastases from malignant melanoma. Cancer 1980; 45: 679–683.
19.Rofstad, EK. Radiation biology of malignant melanoma. Acta-Radiol (Oncol), 1986; 25: 1–10.
20.Rofstad, EK. Growth and radiosensitivity of malignant melanoma multicellular spheroids initiated directly from surgical specimens of tumours in man. Br J Cancer 1986; 54: 569–578.
21.Overgaard, J. The role of radiotherapy in recurrent and metastatic malignant melanoma: A clinical radiobiological study. Int J Radiet Oncol Biol Phys 1986; 12: 867–872.
22.Ziegler, JC, Cooper, JS. Brain metastases from malignant melanoma: Conventional vs. high dose per fraction radiotherapy. Int J Radiat Oncol Biol Phys 1986; 12: 1839–1842.
23.Richmond, A, Fine, F, Murray, D, et al. Growth factor and cytogenetic abnormalities in cultured nevi and malignant melanomas. J Invest Dermatol 1986; 86: 295–302.
24.Kim, MK, Warren, TC and Kimball, ES. Purification and characterization of a low molecular weight transforming growth factor from the urine of melanoma patients. J Biol Chem 1985; 260: 9237–9243.
25.Ellis, DL, Kafka, SP, Chow, JC, et al. Melanoma, growth factors, acanthosis nigricans, the sign of Leser-Trélat and multiple acrochordons. A possible role for alpha-transforming growth factor in cutaneous paraneoplastic syndromes. N Engl J Med 1987; 317: 1582–1587.
26.Derynck, R, Goeddel, DV, Ullrich, A, et al. Synthesis of messenger RN As for transforming growth factors a and β and the epidermal growth factor receptor by human tumours. Cancer Res 1987; 47: 707–712.